133 related articles for article (PubMed ID: 3926900)
1. Retention of biological activity following radioiodination of human interleukin 2: comparison with biosynthetically labeled growth factor in receptor binding assays.
Robb RJ; Mayer PC; Garlick R
J Immunol Methods; 1985 Jul; 81(1):15-30. PubMed ID: 3926900
[TBL] [Abstract][Full Text] [Related]
2. Radioiodination of interleukin 2 to high specific activities by the vapor-phase chloramine T method.
Siekierka JJ; DeGudicibus S
Anal Biochem; 1988 Aug; 172(2):514-7. PubMed ID: 3263816
[TBL] [Abstract][Full Text] [Related]
3. Self-association of interleukin 2 bound to its receptor.
Kaplan D; Smith D; Huang R; Yildirim Z
FASEB J; 1995 Aug; 9(11):1096-102. PubMed ID: 7649410
[TBL] [Abstract][Full Text] [Related]
4. Corticosteroid-interleukin 2 interactions: inhibition of binding of interleukin 2 to interleukin 2 receptors.
Horst HJ; Flad HD
Clin Exp Immunol; 1987 Apr; 68(1):156-61. PubMed ID: 3115640
[TBL] [Abstract][Full Text] [Related]
5. The suppressive effect of gangliosides upon IL 2-dependent proliferation as a function of inhibition of IL 2-receptor association.
Robb RJ
J Immunol; 1986 Feb; 136(3):971-6. PubMed ID: 3079806
[TBL] [Abstract][Full Text] [Related]
6. Low and high affinity cellular receptors for interleukin 2. Implications for the level of Tac antigen.
Robb RJ; Greene WC; Rusk CM
J Exp Med; 1984 Oct; 160(4):1126-46. PubMed ID: 6090574
[TBL] [Abstract][Full Text] [Related]
7. A new assay for interleukin-1 in the presence of interleukin-2.
Falk W; Krammer PH; Männel DN
J Immunol Methods; 1987 May; 99(1):47-52. PubMed ID: 3106502
[TBL] [Abstract][Full Text] [Related]
8. Receptors for T cell-replacing factor/interleukin 5. Specificity, quantitation, and its implication.
Mita S; Harada N; Naomi S; Hitoshi Y; Sakamoto K; Akagi M; Tominaga A; Takatsu K
J Exp Med; 1988 Sep; 168(3):863-78. PubMed ID: 3262707
[TBL] [Abstract][Full Text] [Related]
9. Regulation of interleukin 2 receptor expression on a human cytotoxic T lymphocyte clone, synergism between alloantigenic stimulation and interleukin 2.
Jacques Y; Le Mauff B; Godard A; Olive D; Moreau JF; Soulillou JP
J Immunol; 1986 Mar; 136(5):1693-9. PubMed ID: 2936808
[TBL] [Abstract][Full Text] [Related]
10. Autocrine growth stimulation of a human T-cell lymphoma line by interleukin 2.
Duprez V; Lenoir G; Dautry-Varsat A
Proc Natl Acad Sci U S A; 1985 Oct; 82(20):6932-6. PubMed ID: 3931081
[TBL] [Abstract][Full Text] [Related]
11. Structure-function relationships for the IL 2-receptor system. IV. Analysis of the sequence and ligand-binding properties of soluble Tac protein.
Robb RJ; Kutny RM
J Immunol; 1987 Aug; 139(3):855-62. PubMed ID: 3036946
[TBL] [Abstract][Full Text] [Related]
12. Induction and upregulation by interleukin 2 of high-affinity interleukin 2 receptors on thymocytes and T cells.
Reem GH; Yeh NH; Urdal DL; Kilian PL; Farrar JJ
Proc Natl Acad Sci U S A; 1985 Dec; 82(24):8663-6. PubMed ID: 3936041
[TBL] [Abstract][Full Text] [Related]
13. Interleukin 2 (IL 2) up-regulates its own receptor on a subset of human unprimed peripheral blood lymphocytes and triggers their proliferation.
Harel-Bellan A; Bertoglio J; Quillet A; Marchiol C; Wakasugi H; Mishall Z; Fradelizi D
J Immunol; 1986 Apr; 136(7):2463-9. PubMed ID: 3005412
[TBL] [Abstract][Full Text] [Related]
14. The role of interleukin 2 and T11 E rosette antigen in activation and proliferation of human NK clones.
Schmidt RE; Hercend T; Fox DA; Bensussan A; Bartley G; Daley JF; Schlossman SF; Reinherz EL; Ritz J
J Immunol; 1985 Jul; 135(1):672-8. PubMed ID: 3923116
[TBL] [Abstract][Full Text] [Related]
15. Defective cell-mediated immunity in leprosy: failure of T cells from lepromatous leprosy patients to respond to Mycobacterium leprae is associated with defective expression of interleukin 2 receptors and is not reconstituted by interleukin 2.
Mohagheghpour N; Gelber RH; Larrick JW; Sasaki DT; Brennan PJ; Engleman EG
J Immunol; 1985 Aug; 135(2):1443-9. PubMed ID: 2989366
[TBL] [Abstract][Full Text] [Related]
16. Similarities between interleukin-2 receptor number and affinity on activated B and T lymphocytes.
Lowenthal JW; Zubler RH; Nabholz M; MacDonald HR
Nature; 1985 Jun 20-26; 315(6021):669-72. PubMed ID: 3925347
[TBL] [Abstract][Full Text] [Related]
17. Lymphokine-activated killer cell phenomenon. III. Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cells.
Grimm EA; Robb RJ; Roth JA; Neckers LM; Lachman LB; Wilson DJ; Rosenberg SA
J Exp Med; 1983 Oct; 158(4):1356-61. PubMed ID: 6413638
[TBL] [Abstract][Full Text] [Related]
18. [Functional and biochemical characterization of interleukin 2 receptor-associated molecules].
Uede T; Yamaguchi A; Kikuchi K
Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 2):2056-62. PubMed ID: 3111379
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-1 receptors in mouse brain: characterization and neuronal localization.
Takao T; Tracey DE; Mitchell WM; De Souza EB
Endocrinology; 1990 Dec; 127(6):3070-8. PubMed ID: 2147409
[TBL] [Abstract][Full Text] [Related]
20. IL-12: monoclonal antibodies specific for the 40-kDa subunit block receptor binding and biologic activity on activated human lymphoblasts.
Chizzonite R; Truitt T; Podlaski FJ; Wolitzky AG; Quinn PM; Nunes P; Stern AS; Gately MK
J Immunol; 1991 Sep; 147(5):1548-56. PubMed ID: 1715362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
